Corrigendum to: Long-Term Effectiveness of Oral Ferric Maltol vs Intravenous Ferric Carboxymaltose for the Treatment of Iron-Deficiency Anemia in Patients With Inflammatory Bowel Disease: A Randomized Controlled Noninferiority Trial

Detalles Bibliográficos
Autores principales: Howaldt, Stefanie, Domènech, Eugeni, Martinez, Nicholas, Schmidt, Carsten, Bokemeyer, Bernd
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Corrigendum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8889305/
https://www.ncbi.nlm.nih.gov/pubmed/34612489
http://dx.doi.org/10.1093/ibd/izab224
_version_ 1784661364734689280
author Howaldt, Stefanie
Domènech, Eugeni
Martinez, Nicholas
Schmidt, Carsten
Bokemeyer, Bernd
author_facet Howaldt, Stefanie
Domènech, Eugeni
Martinez, Nicholas
Schmidt, Carsten
Bokemeyer, Bernd
author_sort Howaldt, Stefanie
collection PubMed
description
format Online
Article
Text
id pubmed-8889305
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-88893052022-03-02 Corrigendum to: Long-Term Effectiveness of Oral Ferric Maltol vs Intravenous Ferric Carboxymaltose for the Treatment of Iron-Deficiency Anemia in Patients With Inflammatory Bowel Disease: A Randomized Controlled Noninferiority Trial Howaldt, Stefanie Domènech, Eugeni Martinez, Nicholas Schmidt, Carsten Bokemeyer, Bernd Inflamm Bowel Dis Corrigendum Oxford University Press 2021-10-06 /pmc/articles/PMC8889305/ /pubmed/34612489 http://dx.doi.org/10.1093/ibd/izab224 Text en © 2021 Crohn’s & Colitis Foundation. Published by Oxford University Press on behalf of Crohn’s & Colitis Foundation. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Corrigendum
Howaldt, Stefanie
Domènech, Eugeni
Martinez, Nicholas
Schmidt, Carsten
Bokemeyer, Bernd
Corrigendum to: Long-Term Effectiveness of Oral Ferric Maltol vs Intravenous Ferric Carboxymaltose for the Treatment of Iron-Deficiency Anemia in Patients With Inflammatory Bowel Disease: A Randomized Controlled Noninferiority Trial
title Corrigendum to: Long-Term Effectiveness of Oral Ferric Maltol vs Intravenous Ferric Carboxymaltose for the Treatment of Iron-Deficiency Anemia in Patients With Inflammatory Bowel Disease: A Randomized Controlled Noninferiority Trial
title_full Corrigendum to: Long-Term Effectiveness of Oral Ferric Maltol vs Intravenous Ferric Carboxymaltose for the Treatment of Iron-Deficiency Anemia in Patients With Inflammatory Bowel Disease: A Randomized Controlled Noninferiority Trial
title_fullStr Corrigendum to: Long-Term Effectiveness of Oral Ferric Maltol vs Intravenous Ferric Carboxymaltose for the Treatment of Iron-Deficiency Anemia in Patients With Inflammatory Bowel Disease: A Randomized Controlled Noninferiority Trial
title_full_unstemmed Corrigendum to: Long-Term Effectiveness of Oral Ferric Maltol vs Intravenous Ferric Carboxymaltose for the Treatment of Iron-Deficiency Anemia in Patients With Inflammatory Bowel Disease: A Randomized Controlled Noninferiority Trial
title_short Corrigendum to: Long-Term Effectiveness of Oral Ferric Maltol vs Intravenous Ferric Carboxymaltose for the Treatment of Iron-Deficiency Anemia in Patients With Inflammatory Bowel Disease: A Randomized Controlled Noninferiority Trial
title_sort corrigendum to: long-term effectiveness of oral ferric maltol vs intravenous ferric carboxymaltose for the treatment of iron-deficiency anemia in patients with inflammatory bowel disease: a randomized controlled noninferiority trial
topic Corrigendum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8889305/
https://www.ncbi.nlm.nih.gov/pubmed/34612489
http://dx.doi.org/10.1093/ibd/izab224
work_keys_str_mv AT howaldtstefanie corrigendumtolongtermeffectivenessoforalferricmaltolvsintravenousferriccarboxymaltoseforthetreatmentofirondeficiencyanemiainpatientswithinflammatoryboweldiseasearandomizedcontrollednoninferioritytrial
AT domenecheugeni corrigendumtolongtermeffectivenessoforalferricmaltolvsintravenousferriccarboxymaltoseforthetreatmentofirondeficiencyanemiainpatientswithinflammatoryboweldiseasearandomizedcontrollednoninferioritytrial
AT martineznicholas corrigendumtolongtermeffectivenessoforalferricmaltolvsintravenousferriccarboxymaltoseforthetreatmentofirondeficiencyanemiainpatientswithinflammatoryboweldiseasearandomizedcontrollednoninferioritytrial
AT schmidtcarsten corrigendumtolongtermeffectivenessoforalferricmaltolvsintravenousferriccarboxymaltoseforthetreatmentofirondeficiencyanemiainpatientswithinflammatoryboweldiseasearandomizedcontrollednoninferioritytrial
AT bokemeyerbernd corrigendumtolongtermeffectivenessoforalferricmaltolvsintravenousferriccarboxymaltoseforthetreatmentofirondeficiencyanemiainpatientswithinflammatoryboweldiseasearandomizedcontrollednoninferioritytrial

Ejemplares similares